Detalhe da pesquisa
1.
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
N Engl J Med
; 383(5): 426-439, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726529
2.
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Immun Ageing
; 14: 8, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28413427
3.
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.
J Infect Dis
; 213(3): 411-22, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259809
4.
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
N Engl J Med
; 378(24): 2346-2348, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897849
5.
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
Vaccine
; 35(30): 3749-3759, 2017 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28579233
6.
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.
Vaccine
; 31(3): 524-32, 2013 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153449
7.
Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch.
Vaccine
; 27 Suppl 6: G60-6, 2009 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20006142